Gemini Bio to Distribute Celartia Products in the United States


* Gemini Bio adds Celartia’s cell culture products to its portfolio

WEST SACRAMENTO, CA, and COLUMBUS, OH, January 8, 2020 – Gemini Bioproducts, LLC (“Gemini”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced a distribution agreement with Celartia, Inc. Effective immediately, customers can now purchase Celartia’s line of closed, single-use cell culture cassettes directly from Gemini.

Celartia, Inc., manufactures the Petaka G3™, a closed, single-use, disposable cell culture device that automatically regulates dissolved gasses and pH to provide reliable physioxic culture conditions. The Petaka G3 replaces a variety of traditional and advanced cell culture ware and eliminates the need for most environmental control chambers. The Petaka G3 also established a new product category by providing weeks-long, non-frozen, live cell transportation and storage.

Brendan Lucey, Gemini Bio VP of Business Development, stated, “I am extremely excited to add Celartia’s line of single-use solutions to the Gemini portfolio. In addition to supplying all components of cell growth, we now have a host to grow them on. This addition continues our focus on supporting breakthroughs in the cell therapy field with innovative bioprocessing solutions that allow for an easy transition from R&D to manufacturing.”

Aaron Haubner, PhD, Celartia’s Vice President and General Manager, added, “Celartia’s vision is to fundamentally change what people believe is possible in cell culture. Our partnership with Gemini Bio allows us to share that vision with the most advanced cell culture laboratories in the world. This partnership combines Celartia’s innovation and manufacturing expertise with Gemini’s first-rate sales network and potent marketing abilities to better serve the US market.”


About Gemini Bio

Founded in 1985, Gemini is a leading provider of cell culture solutions to the scientific community across cell and gene therapy, biotechnology, and academic research. Gemini also offers contract manufacturing and regulatory consulting services. Gemini’s singular mission is to enhance human life by delivering comprehensive cell culture solutions that enable discovery, development, and production of transformational therapies.  Our national sales force and international distribution network serves cell culture science worldwide. The Company is based in West Sacramento, California.


About Celartia

Founded in 2002 by Dr. Emilio Barbera-Guillem, Columbus Ohio-based, Celartia, Inc. manufactures, sells, and services the Petaka G3, a technologically advanced cell culture, transportation, and storage device that fundamentally changes the way laboratory scientists and clinical researchers work with cells. Celartia’s mission is to advance the practice of cell culture to enable more rapid and meaningful advancements in scientific research and therapeutic product development.